Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Disease × Vincristine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 19 Lymphoma 19 Lymphoma, Large B-Cell, Diffuse 16 Leukemia 11 Lymphoma, Non-Hodgkin 10 Recurrence 9 Burkitt Lymphoma 9 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 6 Lymphoma, Follicular 6 Neoplasms 5 Lymphoma, B-Cell 5 Multiple Myeloma 3 Medulloblastoma 3 Lymphoma, T-Cell, Peripheral 3 Leukemia, Myeloid, Acute 3 Hodgkin Disease 3 Waldenstrom Macroglobulinemia 2 Sezary Syndrome 2 Sarcoma, Ewing 2 Neuroblastoma 2 Neoplasms by Histologic Type 2 Myelodysplastic Syndromes 2 Mycosis Fungoides 2 Lymphoma, T-Cell, Cutaneous 2 Lymphoma, T-Cell 2 Lymphoma, Large-Cell, Anaplastic 2 Lymphoma, Extranodal NK-T-Cell 2 Lymphatic Diseases 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Leukemia, Biphenotypic, Acute 2

Interventions

obinutuzumab 1 ioflupane 1 idelalisib 1 daratumumab 1 alovudine 1 Vindesine 1 Vincristine 1 Rituximab 1 Prednisone 1 Positron Emission Tomography Computed Tomography 1 Mitomycin 1 Magnetic Resonance Spectroscopy 1 Lenalidomide 1 Ga(III)-DOTATOC 1 Doxorubicin 1 Dexamethasone 1 Cyclophosphamide 1 Bleomycin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01659099 2018-03-07

GAINED

The Lymphoma Academic Research Organisation

Phase 3 Terminated

Disease, Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡